ClinicalTrials.gg
CompletedNCT03576365Updated Feb 10, 2025

Dysphonia, Distress, and Perceived Control: Technology Based Assessment and Intervention

An interventional study of VOICE Intervention Arm and Information-Only Arm in Functional Dysphonia, Voice Disorders and Dysphonia, sponsored by University of Minnesota. Completed at 2 sites in United States. Open to participants aged 18 Years to 80 Years. Per ClinicalTrials.gov, last updated 2025-02-10.

Primary conditionDysphoniaRegistry: Voice DisordersReclassifiedWhy we changed it
Registry
Voice Disorders — the first condition term the registry derived for this study.
ClinicalTrials.gg
Dysphonia
Why
  1. The study's listed conditions name Dysphonia, a narrower term within Voice Disorders.
Confidence
High: the new condition is named in the study's own listed conditions. Of 351 hand-checked studies reclassified this way, 68% were exactly right and 84% in the right disease family; the registry's first term was right for 5% (measured 2026-10-21). How we classify →
Wrong?
Tell us the study's main condition →

Sponsored by University of Minnesota · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 2 years after the study started (first participant enrolled Apr 2016, registered May 2018).
Phase
Not applicable
Study type
Interventional
Enrollment
70
Allocation
Randomized
Ages
18 Years to 80 Years
Sex
All
01

Study summary

The purpose of this study is to pilot test a version of the intervention that has been tailored for participants with dysphonia. The study seeks to determine if the adapted intervention: a) increases perceived control over voice-related stressors and b) decreases stress and distress resulting from voice problems. The study will also explore the usability and acceptability of the program. The goal is to help people with voice problems achieve better voice and quality of life outcomes.

Read the detailed description

In the investigator's voice clinic, a high prevalence of severe distress has been identified. Distress and voice handicap were positively correlated, and perceived control moderated the relationship. Perceived control is associated with less distress in a variety of medical conditions, has an impact beyond that of coping and personality, and can be increased via targeted intervention.

This is a randomized controlled trial. Participants will be randomly assigned to one of the two groups. Both groups involve completing surveys and receiving information online about voice problem.

Participants complete an initial baseline assessment focused on voice function and emotions, including items from the Perceived Control Scale, Voice Handicap Index-10, Perceived Stress Scale, Brief Symptom Inventory-18. Finally, the participants will complete some brief feedback questions about the material.

Next, twice a week for up to three weeks participants will complete check-ins from the online program. Participants in the intervention arm will complete self-guided exercises and brief assessment questions. Participants in the information-only arm will complete mini knowledge quizzes.

All participants will complete brief a post-intervention assessment parallel to the baseline assessment. Lastly, they will have an opportunity to provide final feedback on their experience.

Follow-up with each participant will occur one and three months after finishing the program. Questionnaires will be sent via email including Voice Handicap Index-10, Present Perceived Control-8, and questions regarding treatment adherence and voice outcomes.

02

Conditions studied

  • Functional Dysphonia
  • Voice Disorders
  • Dysphonia

Browse trials for

Keywords

  • Perceived Control
  • Distress
03

In context

Dysphonia Reclassified

132 studies on the registry are indexed under Dysphonia; 38 are open to participants now.

This study's planned enrollment of 70 is above the median of 30 across 87 interventional studies indexed under Dysphonia.

Browse Dysphonia studies →

Lead sponsor

University of Minnesota is the lead sponsor of 1,216 studies on the registry; 197 are open to participants now.

Of its 136 completed or terminated interventional studies of FDA-regulated products, 95 (70%) have results posted.

Compared within Dysphonia, this study's primary condition as ClinicalTrials.gg classifies it; the registry's first condition term is Voice Disorders. The counts are of registry records indexed under each term, refreshed daily. How we classify →

04

Who can participate

Ages eligible
18 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Patients who are seen at the Otolaryngology Clinic (University of Minnesota Health Clinics and Surgery Center, or Fairview Hospital Maple Grove or Southdale) with Muscle Tension Dysphonia
  2. Patients between 18-80 years of age experiencing a voice problem
  3. Scored high (>10) on the Voice Handicap Index (VHI-10)
  4. Has the ability to complete process
  5. Interested in using an online program/intervention
  6. Has reliable access to internet

Exclusion criteria

Exclusion Criteria:

  1. Patients who have clinical need for concurrent treatment will be excluded to decrease confounding introduced by having multiple simultaneous interventions. This may include:

    1. Concurrent laryngeal lesion requiring immediate operative or other intervention
    2. Concurrent participation in speech therapy
    3. Concurrent need for new medications that may directly affect voice-related symptoms
  2. Participant has a Speech Language Pathology visit scheduled in two weeks or less from when they will start the program (if applicable)
  3. Unable to read English (as determined by their ability to complete the clinic intake forms)
  4. Female and pregnant
  5. Prisoner
  6. Unable to provide (e.g., patients with dementia)
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
70 participants (estimated)

Study arms

  • Experimental
    VOICE Intervention Arm

    Participants participate in the online VOICE program to learn about perceived control and stress reduction to improve voice outcomes.

    Behavioral: VOICE Intervention Arm

  • Sham comparator
    Information-Only Arm

    Participants participate in the information only program to learn about voice problems, anatomy and physiology.

    Behavioral: Information-Only Arm

Interventions

  • BehavioralVOICE Intervention Arm

    Introductory and background information about voice problems and psychosocial distress * Examples of concerns raised by patients with voice problems (e.g., "I feel left out of conversations because of my voice problem") * Information about perceived control and how improving perceived control can lead to decreased distress * Examples of strategies that have helped patients identify controllable and uncontrollable aspects of their voice problems (e.g., "I learned to plan to take breaks to rest my voice between teaching classes") * Self-guided exercises designed to help improve perceived control and develop better management skills for voice problem symptoms

  • BehavioralInformation-Only Arm

    General introduction of the program and background on voice related information in an interactive manner * Examples of what patients want to learn more about the voice (e.g., "I would like to learn more about how the voice works when it is healthy") * Information on the anatomy of the voice and how the voice works * Educational materials to help understand voice physiology and function * Self-guided learning exercises (e.g., "what are some things about vocal function that you would like to learn more about?")

06

What researchers measure

Primary outcomes

  1. Perceived Control

    Change from baseline assessment using a questionnaire, Perceived Present Control-8 (PPC-8). The PPC-8 questionnaire has 8 questions about perceptions of present control over their voice problem, assessed on a 4-point Likert-type scale, with scores of 1-4 (1=Strongly Disagree, 2=Disagree Somewhat, 3=Agree Somewhat, 4=Strongly Agree). Total scores range from 1-32. Higher scores indicate more perceived control over the patient's voice problems.

    Time frame: 2 weeks

Secondary outcomes

  1. Voice Handicap

    Change from baseline assessment using a questionnaire, Voice Handicap Index-10 (VHI-10). The VHI-10 questionnaire has 10 questions about voice problems and the effect it has on the patients life, assessed on a 4-point Likert-type scale, with scores of 0-4 (0=Never, 1=Almost Never, 2=Sometimes, 3=Almost Always, 4=Always). Total scores range from 0-40. Higher scores indicate a more problematic voice. The clinical cutoff for a problematic voice is a VHI-10 score of 10, where scores \>10 indicate voice problems. A change of at least 6 points is clinically significant.

    Time frame: 2 weeks

  2. Perceived Stress

    Change from baseline assessment using a questionnaire, Perceived Stress Scale-4 (PSS-4). The PSS-4 questionnaire has 4 questions about perceived stress, assessed on a 5-point Likert-type scale, with scores of 0-4 (0=Never, 1=Almost Never, 2=Sometimes, 3=Fairly Often, 4=Very Often). Total scores range from 0-16. Higher scores indicate more perceived stress in the patient's life.

    Time frame: 2 Weeks

  3. Psychological Symptoms

    Change from baseline assessment using a questionnaire, Brief Symptom Inventory-18 (BSI-18). The BSI-18 questionnaire has 18 questions about psychological symptoms, assessed on a 5-point Likert-type scale, with scores of 0-4 (0=Not at all, 1=A little bit, 2=Moderately, 3=Quite a bit, 4=Extremely). Total scores range from 0-72. Higher scores indicate more extreme psychological symptoms. Patients with "High Risk" psychological symptoms have a score of 57 (75 percentile) or greater.

    Time frame: 2 weeks

Other outcomes

  1. Intervention Module Acceptability

    Examine the acceptability and usability of the adapted intervention based on feedback from participants via a questionnaire.

    Time frame: Baseline and at 2 weeks

  2. Patients' Adherence to Voice Therapy and Treatment

    Examine treatment adherence indicators available in the participants' medical charts after intervention is completed (e.g.., did they attend recommended speech therapy sessions, how adherent were they to their speech therapy exercise regimens, how many visits did it take for them to reach treatment goals). This will be assessed through a medical chart review and reported as a percent of sessions attended, percent exercises completed, and number of visits. All measures will be given equal weight and be used together to assess treatment adherence.

    Time frame: 2 weeks to 2 years

07

Study locations

2 sites
  • University of Minnesota Health Maple Grove Clinic
    Maple Grove, Minnesota 55369, United States
  • University of Minnesota Health Clinics and Surgeries Otolaryngology Clinic
    Minneapolis, Minnesota 55455, United States
08

References and documents

Publications

  • Rosen CA, Lee AS, Osborne J, Zullo T, Murry T. Development and validation of the voice handicap index-10. Laryngoscope. 2004 Sep;114(9):1549-56. doi: 10.1097/00005537-200409000-00009. PubMed 15475780 ↗
  • Frazier P, Keenan N, Anders S, Perera S, Shallcross S, Hintz S. Perceived past, present, and future control and adjustment to stressful life events. J Pers Soc Psychol. 2011 Apr;100(4):749-765. doi: 10.1037/a0022405. Erratum In: J Pers Soc Psychol. 2011 Apr;100(4):718. PubMed 21299308 ↗
  • Cohen S, Kamarck T, Mermelstein R. A global measure of perceived stress. J Health Soc Behav. 1983 Dec;24(4):385-96. No abstract available. PubMed 6668417 ↗
  • Derogatis LR. BSI 18 (Brief Symptom Inventory 18): Administration, Scoring, and Procedures Manual. Bloomington, MN: NCS Pearson; 2000

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 10, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03576365
Responsible party
Sponsor
First posted
Jul 3, 2018
Start date
Apr 11, 2016
Primary completion
Jan 14, 2025
Completion
Jan 14, 2025
Last update
Feb 10, 2025

Study contacts

Stephanie Misono, MD, MPH
principal investigator · University of Minnesota

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Feb 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion